Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Viracta Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.81
15.04.24
€3.00
31.10.25
-
15.04.24

Could be very worthwhile Investment >20% year
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€856.40
14.04.24
-
14.04.25
-1.00%
12:06

buy
aTyr Pharma Inc

Start price
Target price
Perf. (%)
€1.66
14.04.24
-
14.04.25
-13.86%
28.04.24

Could be worthwhile Investment >10% per year
buy
Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.51
14.04.24
-
14.04.25
-0.66%
28.04.24

AEterna Zentaris Inc.

Start price
Target price
Perf. (%)
€1.85
14.04.24
-
14.04.25
3.24%
08:42

Trevena Inc.

Start price
Target price
Perf. (%)
€0.35
14.04.24
-
14.04.25
6.46%
30.04.24

buy
Vanda Pharmaceuticals

Start price
Target price
Perf. (%)
€3.86
14.04.24
-
14.04.25
15.54%
30.04.24

buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€856.40
13.04.24
-
13.04.25
-1.00%
12:06

buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€371.25
13.04.24
-
13.04.25
1.78%
11:06

Ampio Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.060
13.04.24
-
13.04.25
-
07.01.23

buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€140.85
13.04.24
-
13.04.25
-0.07%
09:31

buy
MEI Pharma Inc.

Start price
Target price
Perf. (%)
€4.38
13.04.24
-
13.04.25
-
22.07.23

Moleculin Biotech Inc

Start price
Target price
Perf. (%)
€0.41
13.04.24
-
13.04.25
-
21.03.24

Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.07
13.04.24
€1.00
13.04.25
-2.80%
27.04.24

Probably not worthwhile Investment
Lower EBIT Margin than peer group
Bad rating
ROE lower than 10% per year
Inotiv Inc.

Start price
Target price
Perf. (%)
€5.50
13.04.24
€4.00
13.04.25
-32.36%
27.04.24

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Little Investments for future growth
Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.51
13.04.24
€2.00
13.04.25
-0.66%
27.04.24

negative Cash Flow expected
Few uniques
Growths slower than the competition
Below average Marketposition
buy
Alterity Therapeutics Ltd. ADR

Start price
Target price
Perf. (%)
€3.80
13.04.24
€2.00
13.04.25
-56.58%
27.04.24

buy
Moleculin Biotech Inc

Start price
Target price
Perf. (%)
€0.41
12.04.24
€37.58
12.04.25
-
21.03.24

buy
Amgen Inc.

Start price
Target price
Perf. (%)
€251.00
12.04.24
€300.61
12.04.25
3.25%
12:06

buy
Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.48
12.04.24
-
12.04.25
-16.22%
15.04.24

buy
Blueprint Medicines Corp

Start price
Target price
Perf. (%)
€85.00
12.04.24
-
12.04.25
3.81%
11:50

buy
PTC Therapeutics Inc.

Start price
Target price
Perf. (%)
€24.80
12.04.24
€42.32
12.04.25
20.16%
30.04.24

buy
G1 Therapeutics

Start price
Target price
Perf. (%)
€4.30
12.04.24
€11.28
12.04.25
-17.95%
30.04.24

buy
Novo Nordisk A/S ADR

Start price
Target price
Perf. (%)
€119.50
12.04.24
€153.17
12.04.25
-0.42%
12:07

Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€851.20
12.04.24
€676.58
12.04.25
-0.40%
12:06